Showing results (11-20 of 278) with videos related to
Sort By:
Pageof 28
Pharmaceutical Patent Analyst|August 16, 2019
Inhibition of cancer metabolism: a patent landscapeWilliam P Katt, Richard A CerionePharmaceutical Patent Analyst|February 4, 2025
Emerging patents versus brain eating amoebae, Naegleria fowleriRuqaiyyah Siddiqui, David Lloyd, Naveed Ahmed KhanPharmaceutical Patent Analyst|March 1, 2025
PLGA and cancer: a comprehensive patent-based review on the present state of artVenessa Nath, Mohini Singh, Bani Kumar Jana, et al.Pharmaceutical Patent Analyst|February 8, 2025
Contradicting rulings of the US patent office on double patenting jeopardize the generic and biosimilar drugsSarfaraz K NiaziPharmaceutical Patent Analyst|September 17, 2013
Next-generation therapeutic solutions for age-related macular degenerationKhrishen Cunnusamy, Rafael Ufret-Vincenty, Shusheng WangPharmaceutical Patent Analyst|February 4, 2020
Patent spotlight: small-molecule lysine acetyltransferase inhibitors (KATi)James Al BrownPharmaceutical Patent Analyst|May 4, 2023
Riluzole and its prodrugs for the treatment of Alzheimer's diseaseRami A Al-HoraniPharmaceutical Patent Analyst|April 8, 2021
Treatment of solid tumors using bispecific anti-PDL-1/ICOS antibodyMartin Perez-Santos, Maricruz Anaya-Ruiz, Gabriela Sanchez-Esgua, et al.Pharmaceutical Patent Analyst|April 20, 2023
Patent landscape highlighting double-edged scaffold of a WNT5A-agonizing peptide, Foxy5Vikas Yadav, Rubina Islam, Hardeep Singh TuliPharmaceutical Patent Analyst|July 8, 2014
Novel treatment strategies for brain tumors and metastasesSalma E El-Habashy, Alaa M Nazief, Chris E Adkins, et al.Pageof 28